Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Holdings

4,976.06
+64.591.32%
Number of Gainers:20
Number of Losers:42
Number of Flat:3
PE:- -
High:4,984.55
Open:4,928.39
Low:4,926.45
Close:4,911.46
Volume:254.90M
Turnover:27.03B
Market Cap:8.88T
Float Cap:8.41T

Loading ...

Foresight Plans to Acquire 50.01% in a 270MW Capacity European Data Center Development Company

GlobeNewswire
·
Sep 28

EBANX Partners with NetEase Games Club to Expand Local Payment Options in Latin America

Reuters
·
Sep 28

The Stock Market Faces a Triple Threat but it Can Emerge Victorious

Dow Jones
·
Sep 28

Top Premarket Gainers

MT Newswires Live
·
Sep 28

Cowboy Clean Fuels Sells First Durable Carbon Removal Credits in Salesforce-Backed Purchase Through Milkywire

THOMSON REUTERS
·
Sep 28

Snowflake - Net Proceeds to Fund Capped Calls, Repurchase 2027 Notes, and General Corporate Purposes

THOMSON REUTERS
·
Sep 28

Snowflake - Initial Purchasers May Buy up to $200 Mln More 2029 Notes, $300 Mln More 2031 Notes

THOMSON REUTERS
·
Sep 28

Snowflake - Expects to Repurchase for Cash a Portion of 2027 Notes

THOMSON REUTERS
·
Sep 28

Snowflake Announces Proposed Private Placement of $3.5 Billion of 0.00% Convertible Senior Notes

THOMSON REUTERS
·
Sep 28

XPeng Restructures Product Lines from Four to Two, Sources Say

Deep News
·
Sep 28

Nkarta (NKTX) Receives a Buy from Stifel Nicolaus

TIPRANKS
·
Sep 28

Apple, Amazon Face Renewed UK Consumer Lawsuit

MT Newswires Live
·
Sep 28

Four months to complete a one-year goal: Pinduoduo built a 5,000-person team in Xiongan

Deep News
·
Sep 28

Kodiak Sciences Rises After Eye-Disease Drugs Meet Trial Goals

Reuters
·
Sep 28

PDD's Xiongan Workforce Surpasses 5,000 as Platform Governance Gets a Full Upgrade, Accelerating Value Growth in Traditional Industries

Deep News
·
Sep 28

Kodiak Sciences Shares up 32% Premarket After Zenkuda and Tabirafusp-Ted Meet Primary Endpoints in Daybreak Trial in Wet Age-Related Macular Degeneration

THOMSON REUTERS
·
Sep 28

Kodiak Sciences Says Zenkuda Meets Primary Endpoint in Phase 3 Daybreak Wet AMD Trial

Reuters
·
Sep 28

Analysts Are Bullish on Top Healthcare Stocks: RegenXBio (RGNX), Benitec Biopharma (BNTC)

TIPRANKS
·
Sep 28

Zenkuda and Tabirafusp-Ted Meet Primary Endpoints in Pivotal Daybreak Trial in Wamd, with Zenkuda Demonstrating a Potential New Standard-of-Care Profile with Strong Immediacy and Sustained Clinical Effect with Majority of Patients on 24-Week Dosing Interval Using Strict Treat-to-Dryness Real World Retreatment Criteria.

THOMSON REUTERS
·
Sep 28

Kodiak Sciences - Zenkuda Bla Planned for Q4 2026 to Include Five Positive Phase 3 Studies

THOMSON REUTERS
·
Sep 28